Intarcia Therapeutics said it raised $210 million, enabling the biotechnology company to fund late-stage clinical trials for a new diabetes treatment without forming an alliance with a major drug maker.
[ read more ]
info@utahbusiness.com | 90 South 400 West, Ste 650 Salt Lake City, Utah 84101 | (801) 568-0114
Advertise with Utah Business